Steward Partners Investment Advisory’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXDX
AC
GAM
BC
CS
TWA
Steward Partners Investment Advisory's AXDX Position: Q1 2025 in Review
Steward Partners Investment Advisory sold out of Accelerate Diagnostics (AXDX) in Q1 2025, closing a stake of 527 shares — an estimated $632 sold.
Steward Partners Investment Advisory first reported a position in AXDX in Q2 2018 and held it in 25 quarters. The position peaked at $11K in Q2 2019. 43 funds tracked by Wall St. Rank hold AXDX as of Q1 2025.
- Steward Partners Investment Advisory reported no remaining Accelerate Diagnostics position as of Q1 2025 after selling out during the quarter.
- Steward Partners Investment Advisory sold 527 Accelerate Diagnostics shares in Q1 2025, an estimated $632.
- Steward Partners Investment Advisory first reported a position in Accelerate Diagnostics in Q2 2018 and held it in 25 quarters.
- Steward Partners Investment Advisory's Accelerate Diagnostics position peaked at $11K in Q2 2019.
- 43 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2025.
Based on Steward Partners Investment Advisory's 13F filing for Q1 2025, filed 13 May 2025.